Search results

Technologies 4

• Metabolically Labeled CAR-T Cells Against Cancer
  Through a simple and effective metabolic labeling approach, patient-derived T cells engineered to carry immune-enhancing cytokines on their surfaces could help expand adoptive T cell therapies to treatment of solid tumors and improve blood cancer therapies.
• SomaCode: Getting Cell Therapies Where They Need to Go
  SomaCode is solving the problem of cell therapy delivery by identifying unique molecular “zip codes” for disease and engineering cells to home to those zip codes, making cell therapies safer and more effective.
• DNA Nanoswitches: “Lab-on-a-Molecule” Drug Discovery
  The Lab-on-a-Molecule platform leverages the Wyss Institute’s DNA nanotechnology technology for the high-throughput, low-cost screening of a wide range of chemical and biologic compounds to enable the discovery of first-in-class therapeutics for various conditions.
• eRNA: Controlled Enzymatic RNA Oligonucleotide Synthesis
  Synthetic RNA oligonucleotides designed as specific successions of the four nucleobases A, U, G, and C that mimic naturally occurring RNA species are the key components of diverse RNA-based therapies. These include RNA therapeutics that can partially or completely turn off the expression of disease-causing genes (antisense and interfering RNAs), help replace or supplement dysfunctional...

Collaborations 1

• Northpond Labs Alliance
  Our alliance with Northpond Labs supports early-stage, transformative research with strong translational potential as part of a collaborative Laboratory for Bioengineering Research Innovation.

News 5

View all

• Community
  
  The Wyss Institute and Northpond Ventures’ relationship is moving full steam ahead
  October 26, 2023
• Press Release
  
  Wyss Institute’s Lab-on-a-Molecule Drug Discovery Project Receives Funding from Northpond Labs
  April 4, 2023
• Translation News
  
  Wyss Institute at Harvard University partners with Northpond Labs to launch RNA solutions company EnPlusOne Biosciences
  December 19, 2022

Multimedia 1

• 

  Video/Animation
  Reimagine the World – Volume 3 – Northpond Edition
  The Wyss Institute’s alliance with Northpond Labs supports early-stage, transformative research with strong translation potential. Hear Northpond Ventures co-founders Michael Rubin and Sharon Kedar explain why they decided to partner with the Wyss, as well as the leaders of various Wyss projects and startups about how support from Northpond has helped accelerate their technologies to...